Novacyt S.A. (AIM:NCYT)

London flag London · Delayed Price · Currency is GBP · Price in GBX
46.05
-2.25 (-4.66%)
Jun 3, 2025, 4:35 PM GMT+1
-17.77%
Market Cap 33.75M
Revenue (ttm) 19.63M
Net Income (ttm) -41.76M
Shares Out n/a
EPS (ttm) -0.59
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 107,167
Average Volume 144,056
Open 48.40
Previous Close 48.30
Day's Range 45.20 - 48.40
52-Week Range 36.00 - 137.00
Beta n/a
RSI 58.17
Earnings Date May 30, 2025

About Novacyt

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2006
Employees 234
Stock Exchange London Stock Exchange AIM
Ticker Symbol NCYT
Full Company Profile

Financial Performance

In 2024, Novacyt's revenue was 19.63 million, an increase of 84.82% compared to the previous year's 10.62 million. Losses were -41.76 million, 47.6% more than in 2023.

Financial Statements

News

Novacyt SA (NVYTF) Q2 2024 Earnings Call Transcript Highlights: Key Financial Metrics and ...

Novacyt SA (NVYTF) Q2 2024 Earnings Call Transcript Highlights: Key Financial Metrics and Strategic Insights

8 months ago - GuruFocus

Half Year 2024 Novacyt SA Earnings Call Transcript

Half Year 2024 Novacyt SA Earnings Call Transcript

8 months ago - GuruFocus

Novacyt S.A. (NVYTF) Q4 2023 Earnings Call Transcript

Novacyt S.A. (OTCPK:NVYTF) Q4 2023 Earnings Conference Call May 30, 2024 6:00 AM ET Company Participants Lyn Rees - CEO Steve Gibson - CFO Conference Call Participants Operator [abrupt start] and welc...

1 year ago - Seeking Alpha

Novacyt S.A. (NVYTF) Q2 2023 Earnings Call Transcript

Novacyt S.A. (OTC:NVYTF) Q2 2023 Earnings Conference Call September 28, 2023 7:30 AM ET Company Participants James McCarthy - Acting CEO Steve Gibson - Group Finance Director Lyn Rees - Executive Dire...

1 year ago - Seeking Alpha

Novacyt S.A. (NVYTF) Q4 2022 Earnings Call Transcript

Novacyt S.A. (OTCPK:NVYTF) Q4 2022 Results Conference Call April 27, 2023 7:00 AM ET Company Participants James McCarthy - Acting Chief Executive Officer Steve Gibson - Group Finance Director Operator...

2 years ago - Seeking Alpha

Novacyt S.A. (NVYTF) Q2 2022 Earnings Call Transcript

Novacyt S.A. (OTCPK:NVYTF) Q2 2022 Earnings Conference Call September 29, 2022 7:00 AM ET Company Participants David Allmond - Chief Executive Officer James McCarthy - Chief Financial Officer Conferen...

2 years ago - Seeking Alpha

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Half Year 2022 Results

PARIS & CAMBERLEY, England--(BUSINESS WIRE)--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited results for the ...

2 years ago - Business Wire